References
Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 59(1):8–15
Gowers CJ, Parr MJ (2005) Recombinant activated factor VIIa use in massive transfusion and coagulopathy unresponsive to conventional therapy. Anaesth Intensive Care 33(2):196–200
Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352(8):777–785
Lusher JM (1994) Use of prothrombin complex concentrates in management of bleeding in hemophiliacs with inhibitors–benefits and limitations. Semin Hematol 31[Suppl 4]:49–52
Levi M, Peters M, Buller HR (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33(4):883–890
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hasper, D., Storm, C., Seehofer, D. et al. Both sides of the story – cerebral infarction after intra-abdominal bleeding. Intensive Care Med 32, 340–341 (2006). https://doi.org/10.1007/s00134-005-0008-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-005-0008-2